Sat.Jan 04, 2025 - Fri.Jan 10, 2025

article thumbnail

Five Key Skills for Pharmacy Residents

IDStewardship

In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside

article thumbnail

Challenges for Pharmacies in 2025: What to Expect and How to Prepare

Drug Topics

Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professionals mind as they start the new year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: FDA’s new guidance on AI in drug development centers the risk introduced by the technology

STAT

After nearly a decade of machine learning innovation in the drug industry, the Food and Drug Administration Monday published its first draft guidance on the use of artificial intelligence in the development of drugs and biological products. The guidance comes as drug regulatory submissions citing AI have increased exponentially. In an interview with STAT in October, the FDA’s Tala Fakhouri, who co-leads the Center for Drug Evaluation and Research’s AI Council, said the agency has r

FDA 135
article thumbnail

PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?

PharmaVoice

How regulators could hit PBMs from multiple sides in the coming year.

325
325
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA issues first recommendations on AI for drug development

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

FDA 105
article thumbnail

Pain, Anxiety Main Predictors of Decreased Quality of Life in Long COVID

Drug Topics

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.

529
529

More Trending

article thumbnail

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win

PharmaVoice

Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.

279
279
article thumbnail

Wegovy maker Novo Nordisk sponsored British pharmacies in pursuit of sales

The Guardian - Pharmaceutical Industry

Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions The Danish drug company Novo Nordisk provided hundreds of thousands of pounds worth of sponsorship to pharmacies including Boots and Lloyds as it sought to boost sales of its slimming drugs in Britain, the Observer can reveal.

101
101
article thumbnail

Simultaneous COVID-19, Influenza Vaccines Comparable with Sequential Immunization

Drug Topics

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Vaccines 527
article thumbnail

STAT+: Investors call on UnitedHealth to disclose human and economic costs of policies that limit care

STAT

Seven UnitedHealth Group shareholders are calling on the health care conglomerate to produce a report on how often its policies lead to denied or delayed care, and the effects on patients and the economy.  The proposal , which could go up for a vote by UnitedHealth’s investors at the company’s annual meeting later this year, comes as the company is under tremendous public scrutiny for tactics such as prior authorization and care denials.

Insurance 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

3 trial readouts that could shake up the obesity market this year

PharmaVoice

A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.

276
276
article thumbnail

What is compounded semaglutide made of?

The Checkup by Singlecare

Semaglutide is an active ingredient in a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. These prescription drugs are used to treat Type 2 diabetes, promote weight loss , and reduce the risk of heart disease. Common brand-name drugs that contain this ingredient include Ozempic , Wegovy , and Rybelsus all manufactured by Novo Nordisk, a Danish pharmaceutical company.

article thumbnail

Severe Case Results in First US Bird Flu Death

Drug Topics

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

Hospitals 466
article thumbnail

STAT+: Pharmalittle: We’re reading about a FTC PBM report, a Kroger deal on opioids, and more news

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do plan to promenade with the official mascots, catch up on our reading and hold a listening party with Mrs. Pharmalot, where the rotation will likely include this , this , this , this and this.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

PharmaVoice’s Crystal Ball: Industry shifts in R&D, policy and clinical trials

PharmaVoice

Coming changes that could impact pharma from drug development to launch.

247
247
article thumbnail

Is gabapentin breastfeeding safe?

The Checkup by Singlecare

Gabapentin is a prescription medication used to treat nerve pain and epilepsy. Although gabapentin is an anticonvulsant , its often used off-label to treat restless legs syndrome (RLS) and other nerve conditions or neuropathic pain. It can also treat postherpetic neuralgia, a type of pain that happens after having shingles. Brand names include Neurontin and Gralise.

Dosage 98
article thumbnail

FDA Clears DASH SARS-CoV-2, Flu A/B Combination Test

Drug Topics

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

FDA 467
article thumbnail

Pharma’s big patent cliff, more obesity fundraising, and a failed ALS study

STAT

Why could we see more deal-making at this year’s J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation? And what are the hosts’ New Year’s resolutions? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

4 closely-watched FDA approval dates in 2025 from Vertex, Novo, J&J and more

PharmaVoice

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in the new year.

FDA 214
article thumbnail

As Wildfires Spread Across California, Pharmacists' Role in the Crisis Proves Essential

Pharmacy Times

As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.

162
162
article thumbnail

Sugar-Sweetened Beverages Lead to Millions of New Diabetes, CVD Cases Yearly

Drug Topics

Investigators of a recent study said targeted interventions are needed to reduce the global burden, particularly in developing countries.

384
384
article thumbnail

Opinion: STAT+: Why isn’t AI transforming biopharma as fast as we’d like?   

STAT

The acceleration of artificial intelligence is arriving just in time for the biopharmaceutical industry. The global demand for innovative, effective treatments is  growing faster  than ever as the world’s largest drugmakers face intensifying regulatory, pricing, and political pressure. In this challenging environment, traditional industry processes must simply move faster.

120
120
article thumbnail

PharmaVoice’s Crystal Ball: The industry’s AI future

PharmaVoice

How AI will further transform the business of drug discovery and development in 2025.

202
202
article thumbnail

AnaCardio raises $19m in funding round for heart failure candidate

Pharmafile

Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for its novel contractile agents. The round was co-led by Novo Holdings, Pureos Bioventures and Sound Bioventures. AnaCardios AC01 is a calcium sensitising inotrope, selective oral ghrelin receptor (GHSR1a) agonist in development to improve contractility in […] The post AnaCardio raises $19m in funding round for heart failure candidate appeared first on Phar

64
article thumbnail

Pharmacists Must Be Aware of Polypharmacy Risk in Patients With Long COVID

Drug Topics

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

371
371
article thumbnail

STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy

STAT

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

article thumbnail

Subcutaneous options offer convenience for patients — and a valuable window for drugmakers

PharmaVoice

New formulations for under-the-skin application of drugs give pharmas another opening in a crowded market.

147
147
article thumbnail

NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA

Pharmafile

Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease treatment NMD670 orphan drug designation (ODD). NMD670 was previously granted ODD by the FDA for generalised myasthenia gravis in September 2022. NMD670 is a small molecule inhibitor of the skeletal muscle-specific chloride ion channel CIC-1. […] The post NMD Pharmas Charcot-Marie-Tooth disease treatment granted ODD by FDA appeared first on Pharmafile.

FDA 64
article thumbnail

Wildfire Evacuation Requires Patient Preparedness

Drug Topics

As wildfires ravage Los Angeles County, pharmacists can provide crucial support to their patients.

360
360
article thumbnail

STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more

STAT

Top of the morning to you, and a fine one it is, although we concede this may depend on your tolerance for frigid temperatures. Nonetheless, blue skies and a shiny sun are enveloping the Pharmalot campus, where the official mascots are hunting wildlife and we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today, hazelnut mocha) and foraging for items of interest.

FDA 100
article thumbnail

First US Death From H5N1 Bird Flu Reported in Louisiana

Pharmacy Times

The patient was hospitalized after exposure to an infected backyard flock.

Hospitals 145
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine months after its series A round.

142
142
article thumbnail

FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning

Drug Topics

Patients who receive either Pfizer or GSKs respiratory syncytial virus vaccine may be at increased risk of Guillain-Barr syndrome.

Vaccines 307